Cargando…
Uncovering potential downstream targets of oncogenic GRPR overexpression in prostate carcinomas harboring ETS rearrangements
Gastrin-releasing peptide receptor (GRPR) is known to be overexpressed in several human malignancies, including prostate cancer, and has been implicated in multiple important neoplastic signaling pathways. We recently have shown that GRPR is an ERG and ETV1 target gene in prostate cancer, using a ge...
Autores principales: | Santos, Joana, Mesquita, Diana, Barros-Silva, João D., Jerónimo, Carmen, Henrique, Rui, Morais, António, Paulo, Paula, Teixeira, Manuel R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4468336/ https://www.ncbi.nlm.nih.gov/pubmed/26097883 |
Ejemplares similares
-
Potential Downstream Target Genes of Aberrant ETS Transcription Factors Are Differentially Affected in Ewing’s Sarcoma and Prostate Carcinoma
por: Camões, Maria J., et al.
Publicado: (2012) -
Bispecific GRPR-Antagonistic Anti-PSMA/GRPR Heterodimer for PET and SPECT Diagnostic Imaging of Prostate Cancer
por: Mitran, Bogdan, et al.
Publicado: (2019) -
Bioorthogonal Chemistry Approach for the Theranostics of GRPR-Expressing Cancers
por: D’Onofrio, Alice, et al.
Publicado: (2022) -
Preclinical Evaluation of the GRPR-Targeting Antagonist RM26 Conjugated to the Albumin-Binding Domain for GRPR-Targeting Therapy of Cancer
por: Abouzayed, Ayman, et al.
Publicado: (2020) -
GRPR-targeting radiotheranostics for breast cancer management
por: D’Onofrio, Alice, et al.
Publicado: (2023)